Difference between revisions of "WSI21-23-Case-2"

From MGH Learn Pathology
(Updating subject, access, and performer)
(Added status template)
 
Line 75: Line 75:
 
|subject=Z0FBQUFBQmdKVXM2dUhfaVdEQ2ducEE1Q194SkJqVWxoSGZQX0gxQ24zQzMtRWN4ZjVVMl9tbzFNRkk4OHY2eGJsN19TMmNxemJXUG1GNXNIZzN0UnFLaE9qZTd5V3RTdm5XNWRwRDN3bVVIWjRBVk1JYmpuRWM9
 
|subject=Z0FBQUFBQmdKVXM2dUhfaVdEQ2ducEE1Q194SkJqVWxoSGZQX0gxQ24zQzMtRWN4ZjVVMl9tbzFNRkk4OHY2eGJsN19TMmNxemJXUG1GNXNIZzN0UnFLaE9qZTd5V3RTdm5XNWRwRDN3bVVIWjRBVk1JYmpuRWM9
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Aja51
 +
|authoredOn=February 11, 2021 03:17:13 PM
 
}}
 
}}

Latest revision as of 14:14, December 9, 2024

WSI21-23-Case-2
Not provided.
A. LUNG, LEFT LOWER LOBE, WEDGE RESECTION (C1, C3)

Metastatic kinase fusion-related thyroid carcinoma to the lung (2.1 cm, by report), multinodular, with multifocal vessel involvement. Note: The tumor morphology is distinct with a follicular growth pattern and glomeruloid structures. These findings are seen in association with kinase-fusion related carcinomas. B. RIGHT UPPER LOBE MASS, WEDGE RESECTION (A2) Metastatic kinase-fusion related thyroid carcinoma (1.8 cm, by report). Note: There is a dominant tumor nodule with adjacent, discrete tumor foci present in large blood vessels. C. BRAIN, RIGHT OCCIPITAL, EXCISIONAL BIOPSY (B1)

Metastatic kinase fusion-related thyroid carcinoma (0.6 cm, in aggregate).
December 31, 1969 7:00:00 PM